Photo taken from Caryn Lerman/LinkedIn
Mar 14, 2024, 09:38
Caryn Lerman: Dr. Heinz Josef Lenz and his team investigated the potential prognostic and predictive value of HER2 amplification and gene expression using NGS and NanoString data
Caryn Lerman, Director at USC Norris Comprehensive Cancer Center, shared a post on LinkedIn:
“Published in the Journal of Clinical Oncology, Dr. Heinz Josef Lenz, Deputy Director for Research Programs at the USC Norris Comprehensive Cancer Center, and his team investigated the potential prognostic and predictive value of HER2 amplification and gene expression using next generation sequencing (NGS) and NanoString data. The team discovered that HER2 gene expression levels are predictive and prognostic in patients with metastatic colorectal cancer. In the future, HER2 tumor expression may inform treatment selection for patients with low HER2 favoring bevacizumab- versus cetuximab-based therapies.”
Source: Caryn Lerman/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 13, 2024, 23:33
Nov 13, 2024, 23:28
Nov 13, 2024, 23:26
Nov 13, 2024, 23:22
Nov 13, 2024, 23:18
Nov 13, 2024, 19:25